Double umbilical cord blood transplantation in patients with hematologic malignancies using a reduced-intensity preparative regimen without antithymocyte globulin.

Item

http://www.wikidata.org/entity/Q36923436

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Double umbilical cord blood tr ...... ithout antithymocyte globulin.

@en

type

Item

label

Double umbilical cord blood tr ...... ithout antithymocyte globulin.

@en

prefLabel

Double umbilical cord blood tr ...... ithout antithymocyte globulin.

@en

P1476

Double umbilical cord blood tr ...... ithout antithymocyte globulin.

@en

P2093

B M Sandmaier

http://www.w3.org/2001/XMLSchema#string

C Delaney

http://www.w3.org/2001/XMLSchema#string

F B Petersen

http://www.w3.org/2001/XMLSchema#string

F Milano

http://www.w3.org/2001/XMLSchema#string

F Ostronoff

http://www.w3.org/2001/XMLSchema#string

J A Gutman

http://www.w3.org/2001/XMLSchema#string

P McSweeney

http://www.w3.org/2001/XMLSchema#string

T Gooley

http://www.w3.org/2001/XMLSchema#string

P2860

Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome.

Allogeneic hematopoietic stem cell transplantation for the treatment of high-risk acute myelogenous leukemia and myelodysplastic syndrome using reduced-intensity conditioning with fludarabine and melphalan.

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

Double umbilical cord blood transplantation with reduced intensity conditioning and sirolimus-based GVHD prophylaxis.

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.

Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients

Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.

Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing.

P2888

bmt.2012.243

P304

782-786

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2012.243

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rainer F. Storb

P577

2012-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233930226

http://www.w3.org/2001/XMLSchema#string

P698

23241738

http://www.w3.org/2001/XMLSchema#string

P932

3680599

http://www.w3.org/2001/XMLSchema#string